Data / Drug companies / Lansoprazole
Lansoprazole: 58 companies and 120 products in the FDA NDC directory
Lansoprazole is listed in the FDA National Drug Code Directory by 58 companies, with 120 products in commercial distribution. 109 of the products (90.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, delayed release; tablet, orally disintegrating, delayed release; capsule, delayed release pellets, and the newest product started marketing on August 24, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 58
- Products
- 120
- Generic (ANDA) products
- 109 (90.8%)
- Application numbers
- 20
- Routes
- Oral
- Brand names
- Prevacid SoluTab, Prevacid 24 HR, Foster and Thrive Acid Reducer, Careone Acid Reducer, Prevacid
- openFDA record search
- api.fda.gov
Companies that list lansoprazole
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 10 | capsule, delayed release | Generic drugs (ANDA) | May 18, 2020 |
| Bryant Ranch Prepack | 7 | capsule, delayed release | Generic drugs (ANDA) | July 29, 2021 |
| A-S Medication Solutions | 5 | capsule, delayed release | Generic drugs (ANDA) | January 20, 2019 |
| Amazon.com Services LLC | 5 | capsule, delayed release; tablet, orally disintegrating, delayed release | Generic drugs (ANDA) | August 12, 2026 |
| Mylan Pharmaceuticals Inc. | 4 | tablet, orally disintegrating, delayed release; capsule, delayed release pellets | Generic drugs (ANDA) | November 29, 2018 |
| Preferred Pharmaceuticals Inc. | 4 | capsule, delayed release; capsule, delayed release pellets | Generic drugs (ANDA) | August 12, 2026 |
| Teva Pharmaceuticals USA, Inc. | 4 | tablet, orally disintegrating, delayed release; capsule, delayed release | Generic drugs (ANDA) | March 8, 2018 |
| Bryant Ranch Prepack | 3 | capsule, delayed release | Generic drugs (ANDA) | August 24, 2018 |
| Dr. Reddy's Laboratories Limited | 3 | capsule, delayed release | Generic drugs (ANDA) | August 19, 2019 |
| L. Perrigo Company | 3 | capsule, delayed release; tablet, orally disintegrating, delayed release | Generic drugs (ANDA) | March 30, 2023 |
| Takeda Pharmaceuticals America, Inc. | 3 | tablet, orally disintegrating, delayed release; capsule, delayed release | New drug applications (NDA) | August 30, 2002 |
| Walgreen Company | 3 | capsule, delayed release; tablet, orally disintegrating, delayed release | Generic drugs (ANDA) | January 15, 2023 |
| Advanced Rx of Tennessee, LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | June 4, 2018 |
| Ajanta Pharma USA Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | October 18, 2016 |
| American Health Packaging | 2 | capsule, delayed release | Generic drugs (ANDA) | February 17, 2016 |
| Amerisource Bergen | 2 | capsule, delayed release | Generic drugs (ANDA) | April 12, 2022 |
| Ascend Laboratories, LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | January 20, 2019 |
| Aurobindo Pharma Limited | 2 | tablet, orally disintegrating, delayed release | Generic drugs (ANDA) | March 28, 2023 |
| BluePoint Laboratories | 2 | capsule, delayed release | Generic drugs (ANDA) | December 1, 2013 |
| CVS Pharmacy | 2 | capsule, delayed release; tablet, orally disintegrating, delayed release | Generic drugs (ANDA) | March 31, 2019 |
| Camber Pharmaceuticals, Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | May 18, 2020 |
| Cardinal Health 107, LLC | 2 | tablet, orally disintegrating, delayed release | Generic drugs (ANDA) | August 24, 2026 |
| Dr. Reddy's Laboratories Inc. | 2 | capsule, delayed release | Generic drugs (ANDA) | October 1, 2022 |
| Lifestar Pharma LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | June 4, 2018 |
| Macleods Pharmaceuticals Limited | 2 | capsule, delayed release | Generic drugs (ANDA) | November 5, 2024 |
| NorthStar RxLLC | 2 | tablet, orally disintegrating, delayed release | Generic drugs (ANDA) | March 28, 2023 |
| Proficient Rx LP | 2 | capsule, delayed release | Generic drugs (ANDA) | October 15, 2010 |
| Topco Associates LLC | 2 | tablet, orally disintegrating, delayed release; capsule, delayed release | New drug applications (NDA) | July 29, 2021 |
| Wal-Mart Stores Inc | 2 | tablet, orally disintegrating, delayed release; capsule, delayed release | New drug applications (NDA) | March 19, 2019 |
| Xiromed, LLC | 2 | capsule, delayed release | Generic drugs (ANDA) | August 24, 2018 |
| Zydus Lifesciences Limited | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | November 30, 2018 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | November 30, 2018 |
| Asclemed USA, Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | January 20, 2019 |
| Bjwc | 1 | capsule, delayed release | Generic drugs (ANDA) | October 21, 2022 |
| Bryant Ranch Prepack | 1 | capsule, delayed release | Generic drugs (ANDA) | August 24, 2018 |
| Cardinal Health 110, LLC. DBA Leader | 1 | capsule, delayed release | Generic drugs (ANDA) | October 26, 2022 |
| Chain Drug Marketing Association, Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | April 12, 2022 |
| Costco Wholesale Company | 1 | capsule, delayed release | Generic drugs (ANDA) | November 22, 2021 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | capsule, delayed release | Generic drugs (ANDA) | June 9, 2021 |
| Golden State Medical Supply, Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | July 25, 2016 |
| Kroger Company | 1 | tablet, orally disintegrating, delayed release | New drug applications (NDA) | April 5, 2019 |
| Major Pharmaceuticals | 1 | capsule, delayed release | Generic drugs (ANDA) | October 15, 2010 |
| Medcore LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | January 11, 2026 |
| Meijer Distribution Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | June 7, 2021 |
| Mylan Institutional Inc. | 1 | capsule, delayed release pellets | Generic drugs (ANDA) | December 1, 2009 |
| Padagis Israel Pharmaceuticals Ltd | 1 | capsule, delayed release | Generic drugs (ANDA) | July 29, 2021 |
| Publix Super Markets Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | July 27, 2021 |
| Quallent Pharmaceuticals Health LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | October 14, 2022 |
| Redpharm Drug | 1 | capsule, delayed release | Generic drugs (ANDA) | October 15, 2010 |
| Retail Business Services, LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | December 14, 2021 |
| Rite Aid Corporation | 1 | capsule, delayed release | Generic drugs (ANDA) | November 29, 2019 |
| Rugby Laboratories | 1 | capsule, delayed release | Generic drugs (ANDA) | October 26, 2022 |
| Safecor Health, LLC | 1 | capsule, delayed release pellets | Generic drugs (ANDA) | June 16, 2026 |
| Sam's West Inc | 1 | capsule, delayed release | Generic drugs (ANDA) | July 15, 2024 |
| Strategic Sourcing Services LLC | 1 | capsule, delayed release | Generic drugs (ANDA) | September 14, 2023 |
| Target Corporation | 1 | capsule, delayed release | Generic drugs (ANDA) | June 18, 2021 |
| United Natural Foods, Inc. DBA Unfi | 1 | capsule, delayed release | Generic drugs (ANDA) | September 2, 2021 |
| Walmart Inc. | 1 | capsule, delayed release | Generic drugs (ANDA) | July 20, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, delayed release | 91 | 75.8% |
| Tablet, orally disintegrating, delayed release | 20 | 16.7% |
| Capsule, delayed release pellets | 5 | 4.2% |
| Tablet, orally disintegrating | 4 | 3.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 109 | 90.8% |
| New drug applications (NDA) | 11 | 9.2% |
Pharmacologic classes
| Class | Products |
|---|---|
| Proton Pump Inhibitor | 120 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.